Trinity Biotech Financial Statements
Trinity Biotech Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Trinity Biotech Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 144.0 | 118.7 | 98.7 |
| Gross Profit ($ mil.) | 55.7 | 50.8 | 47.3 |
| Operating Income ($ mil.) | (29.4) | 1.9 | 3.2 |
| Total Net Income ($ mil.) | (35.4) | 3.3 | 2.6 |
| Diluted EPS (Net Income) | (1.86) | 0.19 | 0.35 |
Trinity Biotech Quarterly Statements
| Quarter Ending Jun 01 | |
|---|---|
| Revenue ($ mil.) | 9.4 |
| Gross Profit ($ mil.) | -- |
| Operating Income ($ mil.) | -- |
| Total Net Income ($ mil.) | 1.0 |
| Diluted EPS (Net Income) | -- |
Trinity Biotech Stock Quote & Chart
10/15/08 14:34:51 EST •
NASDAQ •
2.72
•
 +0.2000
•
+7.9365 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Trinity Biotech Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.42 | 2.54 | 1.18 |
| Price/Earnings Ratio | -- | 11.32 | 12.25 |
| Price/Book Ratio | 0.44 | 1.98 | 1.11 |
| Price/Cash Flow Ratio | 3.96 | 10.07 | 7.28 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Trinity Biotech Financial Ratios
Trinity Biotech Competitive Intelligence
| Johnson & Johnson | Roche Diagnostics | Siemens Healthcare Diagnostics | |
|---|---|---|---|
| Annual Sales ($ mil.) | 61,095.0 | 215.1 | 198.7 |
| Employees | 119,200 | 2,000 | 2,406 |
| Market Cap ($ mil.) | 174,384.9 | -- | -- |
Competitive Landscape
